Back to search

Michigan State University

Evaluation of therapeutic response of histiocytic sarcoma cell lines to novel small molecule inhibitors of receptor tyrosine kinases

Abstract

dc:description

The current standard of care treatment for canine histiocytic sarcoma (HS) is based on the administration of conventional chemotherapeutic drugs, which results in low percentage of partial and short-term favorable responses. In order to identify novel drug candidates for the treatment of dogs with HS, we investigated the cytostatic activity of a panel of sixteen compounds over two canine HS cell lines. Our results demonstrated that dasatinib, a receptor tyrosine kinase pan-inhibitor, and other novel molecularly-targeted drugs JQ1, a BET bromodomain inhibitor, and bortezomib, a proteasome inhibitor, effectively inhibited the growth of HS cells in vitro. The antiproliferative response of dasatinib was augmented when combined to doxorubicin, a classical chemotherapeutic agent. For all these drugs, the effective inhibitory concentration in vitro was within a clinically achievable and tolerable plasma concentration in vivo, as described in the veterinary and human medicine literature. In this study we identified three molecularly targeted drugs that may represent a promising anticancer strategy for canine HS. Further in vivo studies and clinical trials are needed to fully evaluate therapeutic potential of these drugs in HS in dogs and in similar disorders in humans.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Takada, Marilia
Contributors dc:contributor
  • Yuzbasiyan-Gurkan, Vilma
  • Kiupel, Matti
  • Dervisis, Nikolaos
  • Hauptman, Joseph

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language
English

Identifiers

dc:identifier.*
Identifier
etd:1839
isbn:9781303334061
isbn:1303334062
oclc:931742379
umi:1544076
local:Takada_grad.msu_0128N_12334

Chain of custody

source
Harvested from
Michigan State University
Base URL
d.lib.msu.edu/oai
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Takada, Marilia. Evaluation of therapeutic response of histiocytic sarcoma cell lines to novel small molecule inhibitors of receptor tyrosine kinases. 2013. https://doi.org/doi:10.25335/jec9-qc04